Professor Cleo Goyvaerts | New Models to Explore Lung Cancer and Develop More Effective Treatments
Lung cancer is a complex disease that remains extremely difficult to treat. Unfortunately, the conventional methods used to study it in mice have limitations when testing potential treatments. Professor Cleo Goyvaerts and Professor Hélène Salmon from Vrije Universiteit Brussel, Belgium and Institut Curie, France, respectively, worked with colleagues to develop small 3D models of lung tumours using mouse and human cells to help develop new and more effective treatments.
The Challenges of Treating Lung Cancer
Lung cancer is a leading cause of death across the world. As a complex disease with many subtypes, it can be particularly challenging to treat because it often goes undetected until it reaches an advanced stage, making it harder to treat successfully.
Immunotherapy is a new type of cancer treatment that unleashes the body’s immune system to fight cancer. It has been very successful in treating some types of cancer, but it does not work for everyone. Researchers are working to develop new ways to make immunotherapy more effective, and one approach has been to study the tumour microenvironment (TME).
As the name suggests, the TME is the environment around a tumour. It comprises many different types of cells, including immune cells, stromal cells, and blood vessels. The TME can be very immunosuppressive, meaning that it can suppress the anti-tumour activity of the immune system.
Creating 3D Lung Cancer Models
One way to study the TME is to use 3D tumour spheroids. Spheroids are clusters of cells grown in the laboratory to mimic the structure and function of tumours. Researchers have developed new methods for generating 3D lung tumour spheroids that more closely resemble human lung tumours than traditional 2D cell culture models. These models help us better understand lung cancer and test potential treatments more effectively. By mimicking the real-world conditions of lung cancer patients, these models are instrumental in guiding research efforts toward more effective therapies, ensuring that they hold promise for actual patients.
Professor Cleo Goyvaerts and her team at Vrije Universiteit Brussel in Belgium have introduced a straightforward method for generating murine (mouse-based) and human lung tumour spheroids that mimic the multi-cellular TME. These spheroids can be used to study tumour growth, immune cell infiltration, and response to therapy.
The models were made using lung cancer cells from mice and humans engineered to glow green, making them easy to spot under the microscope. They also used special lung fibroblast cells, which provide support and structure to the tumour. Finally, different types of immune cells were added to develop a new assay to test the effectiveness of immunotherapeutic drugs on these spheroids.
Creating these 3D models was like putting together a puzzle. Professor Goyvaerts and the team had to find the right balance between the cancer cells, fibroblast cells, and immune cells. Their goal was to make models that were strong, consistent in size, and formed small clusters of cancer cells. After some experiments, the team was able to craft reliable 3D lung cancer models to drive forward their research.
Pioneering Drug Combinations in 3D Tumour Models
In recent research, Professor Goyvaerts and the team confirmed the exciting potential of a new drug combination to help the body’s immune system fight lung cancer. Their spheroid model allowed the confirmation of earlier results that the combination of two existing drugs – anti-PD-1 and anti-LAG-3 – effectively kills lung cancer cells in the laboratory. This combination of drugs is now undergoing clinical trials in humans, with findings so far indicating that it is both safe and effective in the treatment of lung cancer.
‘Our uncomplicated and reproducible protocol provides a much-needed tool to advance the study and treatment of lung cancer, especially in the framework of immunotherapy.’
Pioneering Research in Tissue Communication
Collaborating with Professor Ahmed Eissa from Warwick University and Wolverhampton University (both in the UK), Professor Goyvaerts and her team have been investigating how different tissues communicate with each other without the need for animal experiments. This line of work aims to better understand how the bone marrow, representing the main source of tumour infiltrating immune cells, talks to lung tumours. More specifically, the researchers are dedicated to finding new ways to grow bone marrow cells on 3D scaffolds in the vicinity of lung tumour spheroids in the laboratory, use advanced techniques to study these cells at the single-cell level, and figure out how these interactions affect cancer outcomes and responses to treatment.
This innovative model will benefit cancer research by further reducing the need for laboratory animals. It will also improve our understanding of biomarkers for lung cancer patients, leading to more effective treatment decisions.
MEET THE RESEARCHER
Professor Cleo Goyvaerts
Laboratory for Molecular and Cellular Therapy
Department of Biomedical Sciences
Vrije Universiteit Brussel
Professor Cleo Goyvaerts is a prominent figure in the field of cancer immunotherapy. She completed her PhD in 2015 at Vrije Universiteit Brussel (VUB) on antitumor vaccination. She then completed postdoctoral research both at VUB and Mount Sinai Icahn School of Medicine New York. Returning to VUB in 2018, Dr Goyvaerts was appointed Assistant Professor. She is also a VUB Young Leaders Academy Ambassador for EUTOPIA, a European University Alliance backed by the European Commission. Professsor Goyvaerts has earned considerable recognition, including the International Association for the Study of Lung Cancer Young Investigator Award in 2020, for her contributions to cancer immunotherapy. She is currently leading grant-supported research projects exploring bone marrow-lung cancer interactions and T-cell-mediated killing-resistant mechanisms in lung cancer. Beyond her scientific achievements, Professor Goyvaerts is a dedicated science communicator, bridging the gap between cancer research and society.
- Hélène Salmon, Institut Curie, France
- Ahmed Eissa, Warwick University and Wolverhampton
- Kirsten De Ridder, Vrije Universiteit Brussel, Belgium
- Robin Maximilian Awad, Vrije Universiteit Brussel, Belgium
- Hannelore Ceuppens, Vrije Universiteit Brussel, Belgium
- Navpreet Tung, The Tisch Cancer Institute, USA
- Jan-Timon Werle, Institut Curie, France
- Léa Karpf, The Tisch Cancer Institute, USA
- Annie Bernier, Institut Curie, France
Fonds Wetenschappelijk Onderzoek
Kom op Tegen Kanker
Belgian American Educational Foundation
Wetenschappelijk Fonds Willy Gepts of the UZ Brussel
Belgian Council Laboratory Animal Science
Association Pour la Recherche sur le Cancer
Marie Skłodowska-Curie Actions
K De Ridder, N Tung, J Werle, et al., Novel 3D Lung Tumor Spheroids for Oncoimmunological Assays. Advanced NanoBiomed Research, 2022, 2, 2100124. DOI:
REPUBLISH OUR ARTICLES
We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more
Creative Commons Licence (CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
MORE ARTICLES YOU MAY LIKE
Exploring the complexities of residing in disaster-prone areas is challenging for individuals, businesses, and governments. Professor John Freebairn of the University of Melbourne is shedding light on this process, and notes that the benefits of living in disaster-prone areas often outweigh the potential risks. As governments intervene with financial incentives, infrastructure development, and regulatory measures, finding an appropriate balance between short-term relief and long-term resilience is crucial. Professor Freebairn considers the roles of government, information, insurance strategies, and subsidy consequences.
While individual national identities are typically conveyed using a single flag, some nationalists choose to express their identity with two flags. For instance, Christian nationalists in the USA and South Korea have started flying the Israeli flag beside their country’s national flag at right-wing Christian rallies or outside their homes. Dr Amílcar Antonio Barreto and HyungJin Kim, two researchers at Northeastern University, have recently carried out a study exploring the symbolic meaning of this double flag use among Christian nationalists.
In recent years, many European countries have introduced bans that limit or prohibit the use of religious face veils, which include the burqa and niqab. Dr Brenda O’Neill worked with colleagues to examine the role of feminist arguments amongst non-Muslim women in Quebec on the acceptability of wearing the niqab in public spaces. This work explored some additional attitudes underpinning these arguments, identifying how these also shape the diverse beliefs of Canadian women.
Professor Richard Collins – Dr Jintai Li | Project Super Soaker: Investigating High-altitude Polar Ice Clouds with Rockets
Phenomena in the upper atmosphere are difficult to study for several reasons – some rarely form, others are difficult to see, and all are incredibly high up. Polar Mesospheric Clouds (PMCs) are no exception, forming at around 80 kilometres up into the sky, only under specific atmospheric conditions, and only visible to the naked eye during twilight. PMCs are also called noctilucent or ‘night-shining’ clouds, as they appear to glow in the summer nighttime sky. Professor Richard Collins from the University of Alaska Fairbanks is using rockets to seed these clouds, allowing better investigations of both PMCs and the effects of space traffic on our upper atmosphere.